Q BioMed Inc - ESG Rating & Company Profile powered by AI
This webpage includes a questions and answers section about Q BioMed Inc. The analysis of Q BioMed Inc is assembled by All Street Sevva using advanced Cognitive Robots. The webpage is a free E,S&G assessment for Q BioMed Inc.
Q BioMed Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 0.0, social score of 6.4 and governance score of 4.0.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1575 | Vitality Biopharma Inc | 3.6 | Medium |
| 1575 | Zhejiang East Asia Pharmaceutical Co Ltd | 3.6 | Medium |
| 1617 | Q BioMed Inc | 3.5 | Medium |
| 1617 | Anika Therapeutics Inc | 3.5 | Medium |
| 1617 | Aerovate Therapeutics Inc | 3.5 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Q BioMed Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Q BioMed Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Q BioMed Inc report the average age of the workforce?
Sign up for free to unlockDoes Q BioMed Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Q BioMed Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Q BioMed Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Q BioMed Inc offer flexible work?
Sign up for free to unlockDoes Q BioMed Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Q BioMed Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Q BioMed Inc conduct supply chain audits?
Sign up for free to unlockDoes Q BioMed Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Q BioMed Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Q BioMed Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Q BioMed Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Q BioMed Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Q BioMed Inc disclose water use targets?
Sign up for free to unlockDoes Q BioMed Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Q BioMed Inc have a product recall in the last two years?
Sign up for free to unlockDoes Q BioMed Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Q BioMed Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Q BioMed Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Q BioMed Inc disclose parental leave metrics?
Sign up for free to unlockDoes Q BioMed Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Q BioMed Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Q BioMed Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Q BioMed Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Q BioMed Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Q BioMed Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Q BioMed Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Q BioMed Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Q BioMed Inc disclose its waste policy?
Sign up for free to unlockDoes Q BioMed Inc report according to TCFD requirements?
Sign up for free to unlockDoes Q BioMed Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Q BioMed Inc disclose energy use targets?
Sign up for free to unlockDoes Q BioMed Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Q BioMed Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Q BioMed Inc
These potential risks are based on the size, segment and geographies of the company.
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.